TY - JOUR
T1 - Roles of matrix metalloproteinases in the cornea
T2 - A special focus on macular corneal dystrophy
AU - Kaya, Saniye Gul
AU - Inanc-Surer, Seniz
AU - Cakan-Akdogan, Gulcin
AU - Oktay, Gulgun
AU - Utine, Canan Asli
AU - Kalyoncu, Sibel
N1 - Funding Information:
This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) project numbers 318S208 and 219S943.
Publisher Copyright:
© 2021 The Authors
PY - 2021/9
Y1 - 2021/9
N2 - Matrix metalloproteinases (MMPs) are endopeptidases that are responsible for the degradation of several components of the extracellular matrix (ECM) and some non-ECM proteins. MMPs are subdivided into 6 groups according to their structure and substrate specificity: collagenases, gelatinases, membrane-type MMPs, stromelysins, and matrilizines. Collagenases are important proteolytic tools during ECM remodeling, tissue regeneration, and organ development. MMPs, especially collagenases, have important roles in ocular processes such as retinal neurogenesis and corneal wound healing. MMP studies on eye research are limited, but there is growing evidence that MMP physiology is key for the ocular system, especially for the cornea. The cornea is predominantly composed of collagen fibrils, which form uniform lamellar lattices. Collagenase-driven ECM remodeling is essential for the cornea. Macular corneal dystrophy (MCD) is a rare inherited disease and characterized by progressive, insoluble accumulation of irregular substances in the corneal ECM. MCD can cause visual acuity loss up to blindness, and there is currently no treatment available. It has been recently reported that certain collagenases are downregulated in MCD disease progression. Here, we review the roles of MMPs in eye diseases and propose possible treatment strategies for MCD.
AB - Matrix metalloproteinases (MMPs) are endopeptidases that are responsible for the degradation of several components of the extracellular matrix (ECM) and some non-ECM proteins. MMPs are subdivided into 6 groups according to their structure and substrate specificity: collagenases, gelatinases, membrane-type MMPs, stromelysins, and matrilizines. Collagenases are important proteolytic tools during ECM remodeling, tissue regeneration, and organ development. MMPs, especially collagenases, have important roles in ocular processes such as retinal neurogenesis and corneal wound healing. MMP studies on eye research are limited, but there is growing evidence that MMP physiology is key for the ocular system, especially for the cornea. The cornea is predominantly composed of collagen fibrils, which form uniform lamellar lattices. Collagenase-driven ECM remodeling is essential for the cornea. Macular corneal dystrophy (MCD) is a rare inherited disease and characterized by progressive, insoluble accumulation of irregular substances in the corneal ECM. MCD can cause visual acuity loss up to blindness, and there is currently no treatment available. It has been recently reported that certain collagenases are downregulated in MCD disease progression. Here, we review the roles of MMPs in eye diseases and propose possible treatment strategies for MCD.
KW - Collagenases
KW - Cornea
KW - Macular corneal dystrophy
KW - Matrix metalloproteinases
UR - http://www.scopus.com/inward/record.url?scp=85108707658&partnerID=8YFLogxK
U2 - 10.1016/j.medidd.2021.100095
DO - 10.1016/j.medidd.2021.100095
M3 - Review article
AN - SCOPUS:85108707658
SN - 2590-0986
VL - 11
JO - Medicine in Drug Discovery
JF - Medicine in Drug Discovery
M1 - 100095
ER -